Home » Stocks » Acasti Pharma

Acasti Pharma Inc. (ACST)

Stock Price: $0.756 USD -0.024 (-3.03%)
Updated Aug 12, 2020 3:27 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 69.96M
Revenue (ttm) n/a
Net Income (ttm) -19.25M
Shares Out 92.49M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $0.756
Previous Close $0.780
Change ($) -0.024
Change (%) -3.03%
Day's Open 0.782
Day's Range 0.742 - 0.783
Day's Volume 1,064,994
52-Week Range 0.250 - 3.080

More Stats

Market Cap 69.96M
Enterprise Value 59.32M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 92.49M
Float 84.12M
EPS (basic) n/a
EPS (diluted) -0.30
FCF / Share -0.21
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 534,208
Short Ratio 0.08
Short % of Float 0.24%
Beta 1.37
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 5.69
Revenue n/a
Operating Income -18.44M
Net Income -19.25M
Free Cash Flow -17.55M
Net Cash 10.63M
Net Cash / Share 0.11
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -51.13%
ROE -212.26%
ROIC n/a
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$2.90*
(283.40% upside)
Low
0.99
Current: $0.756
High
7.00
Target: 2.90
*Average 12-month USD price target from 4 stock analysts.

Financial Performance

Financial numbers in millions CAD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-24.44-34.41-19.70-11.21-9.61-12.40
Net Income-25.51-39.37-21.50-11.25-6.32-1.66
Shares Outstanding84.5854.2917.4911.0910.6610.62
Earnings Per Share-0.30-0.73-1.23-1.01-0.59-0.16
Operating Cash Flow-22.94-24.79-21.50-11.25-6.57-7.20
Capital Expenditures-0.32-0.53-0.46-2.53-0.28-0.04
Free Cash Flow-23.26-25.32-21.96-13.77-6.85-7.23
Cash & Equivalents14.2425.768.220.0010.470.00
Total Debt0.151.361.61---
Net Cash / Debt14.0924.406.610.0010.470.00
Assets22.8536.9022.96-28.52-
Liabilities9.8625.8514.74-1.30-
Book Value12.9911.058.22-27.22-
Numbers in millions CAD, except per-share numbers.

Company Profile

Company Details

Full Name Acasti Pharma Inc.
Country Canada
Employees 32
CEO Janelle D'Alvise

Stock Information

Ticker Symbol ACST
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ACST

Description

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.